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Abstract.  Sodium orthovanadate,  an inhibitor of pro- 
tein tyrosine phosphatases,  causes increased levels of 
tyrosine phosphorylation and blocks, at noncytotoxic 
concentrations,  the differentiative response of rat pheo- 
chromocytoma (PC12) cells to/3-nerve growth factor 
(/3NGF)  and basic fibroblast growth factor (bFGF) in 
a  reversible manner.  It also prevents growth factor- 
induced neurite proliferation in primed cells and causes 
the retraction of previously formed neurites,  even in 
the presence of/3NGF or bFGE It is equally effective 
in blocking neurite proliferation by 8-Br-cAMP.  Zinc 
chloride and ammonium molybdate, two other inhibi- 
tors of tyrosine phosphatases,  also cause parallel de- 
creases in neurite proliferation.  Orthovanadate gen- 
erally reduces the transcription  of immediate early 
response genes (TIS 8 and c-fos) and secondary re- 
sponse genes (ornithine decarboxylase (ODC),  acetyl- 
cholinesterase (ACHE) and SCG 10) induced by/3NGF, 
bFGF, EGF, and PMA, albeit in a variable fashion. 
There was no observed effect on the kinetics of expres- 
sion as judged by TIS 8 induction by/3NGF and pro- 
tein kinase C  (PKC) downregulation did not change 
the levels of inhibition by orthovanadate seen in con- 
trol cells.  Orthovanadate does not affect the production 
of diacylglycerol induced by/3NGF or bFGE These 
observations are consistent with the view that growth 
factor stimulation of differentiation in PC12 cells in- 
volves at least one other PKC independent pathway, 
and that cAMP and PMA (and their active analogs) 
activate tyrosine kinases (albeit probably secondarily), 
which are at least partially responsible for their ac- 
tions. Although the exact site(s) of action of orthovana- 
date that lead to the inhibition of growth factor-induced 
neurite proliferation are unknown, the results presented 
suggest that it prolongs tyrosine phosphorylations by 
nonreceptor tyrosine kinases that act downstream from 
the receptor kinases. 
~-SEI~VE growth factor (/~NGF), ~ basic fibroblast growth 
factor (bFGF) and many of their homologs act as potent neu- 
rotrophic factors on a variety of neuronal cells in vitro (Levi 
and Alema, 1991; Wagner, 1991). At least in the case of the 
NGF-like  agents  (neurotrophins),  these  effects  extend  to 
many of the same ceils in vivo. One cultured cell line,  re- 
sponsive to both factors, was established from a rat pheo- 
chromocytoma by Greene and Tischler  (1976). Designated 
PC12, these cells adopt a differentiated  phenotype resem- 
bling sympathetic  neurons when treated by/3NGF or bFGF 
(acidic or basic) that is reversed to a chromaflin-cell  pheno- 
type when they are withdrawn.  Among other responses, they 
induce neurite proliferation,  neurite regeneration,  changes 
in ion fluxes, electrical excitability and cholinergic  activities 
(Greene and Tischler,  1982). PC12 cells also possess recep- 
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tors for and are stimulated  by other external  ligands  such 
as EGF, interleukin-6  and carbachol (a muscarinic agonist) 
but these do not necessarily lead to neuronal  differentiation 
(Greene and Tischler,  1982; Satoh et al.,  1988). 
The intraceUular  signals  responsible for the cellular  re- 
sponses  to  /~NGF and  bFGF  in  any  target  cell  are  in- 
completely understood. In PC12 cells, both factors clearly 
stimulate  receptor bound tyrosine kinases  leading  to auto- 
phosphorylation and the induction of a broad variety of intra- 
cellular  protein  phosphorylations  (on  both  tyrosine  and 
serine/threonine  residues)  that results  in the stimulation  of 
phospholipase  C,  (Vetter  et al.,  1991), protein kinase  C 
(PKC) (Cremins  et al.,  1986; Contreras and Guroff,  1987; 
Heasley and Johnson, 1989; Altin and Bradshaw, 1989; Pes- 
sin et al.,  1991), and phosphatidyl  inositol-3-kinase  (Raf- 
fioni and Bradshaw,  1992). In addition,  obligatory roles for 
c-src and c-ras that are apparently independent of these path- 
ways have also been identified (Alema et al., 1985; Bar-Sagi 
and Feramisco, 1985; Kremer et al., 1991). In fact, as  judged 
by immediate-early  response gene induction  (Kujubu et al., 
1987; Damon et al.,  1990; Sigmund  et al.,  1990;  Altin et 
al.,  1991), both PKC-dependent and independent  pathways 
are operative for both factors. 
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tyrosine kinases in a ligand dependent fashion appears essen- 
tial  to initiate  these neurotrophic  responses,  the resulting 
protein  tyrosine phosphorylations  are relatively transitory 
and appear to function as short-lived  intermediates  in the 
signal cascade(s). In this respect, the neurotrophic factor re- 
sponses  may resemble  the  regulation  of the  cell  cycle in 
marine  invertebrates  and yeast which is controlled by the 
phosphorylation/dephosphorylation  of p34  cDc 2S/CDC  2 kinase 
(Nurse,  1990; Matsushime et al.,  1991). 
To further probe the role of tyrosine phosphorylations in 
the/3NGF/bFGF action on PC12 cells, we have examined the 
effect of orthovanadate on various growth factor induced re- 
sponses. This compound is an inhibitor of protein tyrosine 
phosphatases  (PTPases) that,  in concert with the kinases, 
control the level of tyrosine phosphorylation. As an example 
of this function, membrane PTPase activity increases as the 
rate  of cell proliferation  decreases,  reaching  a  maximum 
when cells become contact inhibited (Brautigan and Pinault, 
1991;  Pallen  and  Tong,  1991).  By  analogy  with  phos- 
phodiesterase  inhibitors,  which  prolong  cAMP-dependent 
signals, PTPase inhibition might also be expected to enhance 
~NGF/bFGF responses. However, orthovanadate has proven 
to be a strong inhibitor of neurite proliferation and regenera- 
tion and markedly affects, in a quantitative, but not temporal 
fashion, the expression of several immediate early and sec- 
ondary response genes. It was without effect, however, on the 
production of diacylglycerol (DG).  These findings support 
the view that tyrosine phosphorylation signals are probably 
generally (and necessarily) transitory and that multiple sig- 
nalling pathways exist in response to both growth factors. 
Materials and Methods 
Materials 
~NGF and EGF were prepared by the method of Mobley et al. (1976) and 
Savage and Cohen (1972),  respectively, bFGF used in all experiments was 
an analog with all haif-cystine  residues replaced by serines (Fox et al., 1988) 
(kindly provided by Dr. Michael Fox, Amgen, Inc., Thousand Oaks, CA). 
PMA, 8-Br-cAMP, and sodium orthovanadate were from Sigma Chemical 
Co. (St. Louis, Mo.). Stock solutions of sodium orthovanadate (5 mM)was 
prepared according to Brown and Gordon (1984). 
Cell Culture 
PC12 cells were obtained from Dr. D. Schubert (Salk Institute, San Diego, 
CA). All cells were maintained as monolayer cultures in 150 cm  2 tissue 
culture flasks (Bellco Glass, Inc., Vineland, NJ) in DME containing 10% 
horse serum, 5% FCS, and 1% Fungi-bact solution (complete medium) in 
a 5% CO2 humidified atmosphere. Cells were subcultured once a week by 
shaking the flask and replating in a  1:4 to  1:6 ratio.  The medium was 
changed every 3 d. 
Neurite Outgrowth and Neurite Regeneration 
PC12 cells used for induction of morphological differentiation were subcul- 
tured in collagen-coated 35 mm 6-well cluster dishes at a density of ~0.1 
x  106 cells/well. Cells were first grown in complete medium for 6  h, 
rinsed once with DME, and then cultured in DME containing 1% horse se- 
rum and 1% Fungi-bact solution./3NGF (100 ng/mi), bFGF (10 ng/ml) or 
8-Br-cAMP (1 raM) were added to the medium in the presence or absence 
of various concentrations of inhibitors. After 24 or 48 h of treatment, 2 to 
3 random microscopic fields per well were photographed using a  Nikon 
Diapbot  microscope. The  negatives were examined under  a  microfiche 
reader. Responsive cells were defined as those bearing neurites at least 2 
cell diam in length and with clearly defined growth cones. At least 200 cells 
were scored per negative. For neurite regeneration experiments, cells were 
primed in complete media containing 50 ng/ml BNGF for 7 d. Neurites 
were sheared from cell bodies by vigorously shaking the flask followed by 
a  brief centrifugation and resuspension. Cells were then replated as de- 
scribed above for neurite outgrowth. The proportion of responsive cells was 
examined one  day  after the  readdition of BNGF  with  or  without  or- 
thovanadate. 
Measurement of  PTPase  Activity 
PC12  cells were cultured in 60 ram collagen-coated dishes and pretreated 
with or without PTPase inhibitors (sodium orthovanadate, zinc chloride, or 
ammonium molybdate) for 24 h. Cells were rinsed with PBS and solnbilized 
in 0.15 ml lysis buffer containing 50 mM Hepes (pH 7.4),  10%  glycerol, 
4 mM EDTA,  1 mM dithiothreitol, 1% NP-40, 0.5 mM PMSF,  10 #g/ml 
leupeptin,  and  10  #g/ml  aprotinin.  The  cell  lysate  was  centrifuged at 
14,000  g for 15 rain and the supernatant was used for PTPase assay.  The 
synthetic peptide raytide (Oncogene Science, Uniondale, NY), phosphor- 
ylated on tyrosine residues, was used as the substrate in the PTPase assay. 
Phosphorylation was performed in 0.4  mi  containing 40  tzg of raytide, 
50 mM  Hepes  (pH  7.4),  10  #g  of A-431  cell  membrane particulates, 
1 #g/ml  EGF,  0.25%  NP-40,  10  mM  MnCI2,  0.5  mM  orthovanadate, 
25 #M ATP, and 150 #Ci of h,-32p]ATP for 1 h at 30°C. The reaction mix- 
ture was spotted on P-81 phosphocellulose paper and washed 3 times for 
5 min with 0.5% phosphoric acid. Phosphorylated raytide was eluted from 
the P-81  paper by  10 ml 0.5 M  ammonium bicarbonate and lyophilized. 
Phosphatase assay was performed essentially as described by Streuli et al. 
(1990) except 1 #g of cellular protein was used for each assay and enzyme 
samples were incubated with substrate at 25"C for 10 min. 
Immunoblot Analysis 
PCI2 cells were grown in 100 rnm collagen-coated dishes and pretreated 
with or without 20 #M  orthovanadate for 24 h.  After stimulation with 
growth factors for 5 rain, cells were rinsed with PBS and solubilized in 100 
#1 2  x  SDS sample buffer (Laemmli, 1970)  with the addition of 0.5 mM 
PMSF, 10 t~g/ml leupeptin, 10 #g/ml aprotinin, and 1 mM orthovanedate. 
Samples were boiled for 5 rain and 100 #g of proteins was separated by an 
10%  SDS/PAGE, transferred to an Immunobilon-P membrane (Millipore 
Corp.,  Bedford, MA),  and probed with antiphosphotyrosine antiserum 
(Zymed Labs, South San Francisco, CA) and  125I-protein A. The mem- 
brane was subjected to autoradiography at  -80°C for 6 h. 
Measurement of Ornithine Decarboxylase  Activity 
PC12 cells were grown in 60 nun collagen-coated dishes in complete media 
for 2 d. 1 d before the experiment, media were changed to DME containing 
1% horse serum with or without 10 #M sodium orthovanadate. On the day 
of the experiment, growth factors were added directly to the media for 5 h. 
Cells were then rinsed with PBS and harvested. Preparation of cell extracts 
and estimation of omithine decarboxylase (ODC) activity were essentially 
the same as described by Djurhuus (1981). Protein concentration was deter- 
mined by the method of Bradford (1976)  using BSA as a  standard. ODC 
activities were expressed as nmol putrescine/mg protein/h. 
Measurement of  Acetylcholinesterase  Activity 
PCI2 cells were grown in  100 mm collagen-coated dishes under similar 
conditions as for neurite outgrowth experiment. Cells were treated with 
growth factors with or without 10 #M orthovanadate for 3 d. Cell extracts 
were prepared and acetylcbolinesterase  (ACHE) activities were estimated as 
described by Rieger et al. (1980).  Enzyme activities were expressed as nmol 
thiocholine/mg proteirdmin. 
Measurement of  Diacylglycerol 
PC12 cells were grown in 100 mm collagen-coated dishes in complete me- 
dia for 2 d. Cells were rinsed once with DME and changed to DME in the 
presence or absence of 10 #M orthovanadate and continuously grown over- 
night. After stimulation with growth factors for 5 rain, cells were extracted 
as described by Bligh and Dyer (1959) except that 1 M NaC1 was used as 
the upper phase to prevent acid-catalyzed isomerization of sn-diacylglyc- 
erols (DG).  Two samples of the final CHCI3  phase were dried under a 
stream of N2 for DG and phospholipid measurements. Sn-I,2-DG was esti- 
mated essentially as described by Preiss et al. (1986), as modified by Wright 
et al. (1988).  In all assays, the conversion of a known quantity of sn-DG 
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the method of Ames and Dubin (1960).  Data were expressed as nmol of 
DG/100 nmol of total phospholipids (mole percent). 
Northern Blot Analyses 
PC12 cells were grown in 150 turn collagen coated dishes in complete media 
for 2 d.  1 d before the experiment, ceils were fed with fresh media in the 
presence or absence of  20/~M orthovanadate. On the day of  the experiment, 
growth factors were added directly to the media for the indicated time. Cells 
were at a density ,,°60-70% cortfluency.  To determine SCG 10 expression, 
cells were harvested 24 h after the addition of growth factor and orthovana- 
date. Because the induction of SCG 10 by growth factors was inhibited at 
high cell density, the cell density was maintained at '°30% confluency. Total 
cellular RNA (I0 t~g/lane), isolated as described by Chomezynski and Sac- 
chi (1987),  was fractionated on 0.9 or 1.0% agarose gels containing 2.2 M 
formaldehyde and transferred to a nitrocellulose membrane (Sambrook et 
al., 1989).  DNA probes used were: SCG 10, a 1.9-kb Eco RI fragment from 
the clone SCG 10-3 (Stein et al., 1988a); v-fos, a 1.0-kb Pst I fragment iso- 
lated fromp-fos.1 (Curran et al., 1982); CHOb, a 0.74-kb Barn HI fragment 
(Lira et al., 1987);  and TIS 8, a full-length eDNA (Lim et al., 1987).  (SCG 
10-3  was kindly provided by Dr.  D.  J.  Anderson, California Institute of 
Technology, Pasadena, CA; the v-fos,  TIS  8, and pCHOb probes were a 
generous gift from Dr. Harvey Herschman, University of California, Los 
Angeles, CA). Radioactive probes were prepared using a multiprime DNA 
labeling system by Amersham Corp. (Arlington Heights, IL).  RNA blots 
were prehybridized and hybridized as described by Lim et al.  (1987)  and 
were exposed to  Kodak X-Omat AR films at  -80"C  with  intensifying 
screens for 24 to 48  h. TIS  8 blots were cohybridized with the pCHOb 
probe; other blots were first hybridized with the SCG 10-3 or e-fos probes, 
washed to remove these probes, and then hybridized with the pCHOb probe 
to normalize RNA loading differences. Densitometric scanning of  the corre- 
sponding autoradiograms was used to semiquantitate the expression of  these 
genes after normalization. 
Data Analysis 
Values were reported as mean and SEM. The unpaired t test was used for 
comparisons between two treated groups and the paired t test was used for 
comparisons between treated groups (expressed as fold of  control) and con- 
trol (set as  1.0). Significance level was set at ~  =  0.05. 
Results 
Increase of Growth Factor-stimulated  Protein ])2rosine 
Phosphorylation by Orthovanadate  in PC12 Cells 
The effect of orthovanadate on growth factor-induced protein 
tyrosine phosphorylation in PC12 cells is shown in Fig.  1. 
Consistent with its potent protein tyrosine phosphatase in- 
hibitor  activity,  the  levels  of  tyrosine  phosphorylation 
detected by immunoblot analysis after 5 min are markedly 
enhanced in all orthovanadate treated samples (including un- 
stimulated cells). Within the limits of  this analysis, it appears 
that the pattern of  phosphorylation is not altered with respect 
to any factor although a  few phosphorylated proteins are 
only detectable in the orthovanadate-pretreated cells. How- 
ever, the pattern of  tyrosine phosphorylation for each growth 
factor is  distinct with each  factor showing  at  least  some 
unique bands. 
Inhibition by Orthovanadate  of  Neurite Outgrowth 
Induced by [3NGF, bFGF, and 8-Br-cAMP 
The induction of neurites by/3NGF and bFGF serves as a 
convenient marker  for  the  differentiative action  of these 
growth  factors on PC12  cells.  Although a  relatively long 
term response, it is clearly connected to a variety of intracel- 
lular changes including the rapid,  ligand-dependent phos- 
phorylation of tyrosine residues  in  a  variety of proteins, 
Figure 1. Effect if orthovanadate on increased growth factor-stimu- 
lated tyrosine phosphorylation in PC12 cells. PC12 ceils pretreated 
with or without 20 #M orthovanadate for 24 h were stimulated with 
/3NGF (100 ng/ml), bFGF (10 ng/ml), or EGF (3 ng/ml) for 5 min. 
100 t~g of  total cellular proteins were separated by 10% SDS PAGE 
and immunoblotted with antiphosphotyrosine antibody and  t2sI- 
protein A. The migration of molecular weight standards is shown 
on the left. 
modifications that are among the earliest observed effects. 
Thus, orthovanadate, a potent inhibitor of PTPases, might be 
expected to affect positively growth factor induced processes 
such as neurite proliferation. However, as shown in Figs. 2 
a  and 3, incubation of PC12 cells with NGF or bFGF for 2 
days in the presence of 1/xM orthovanadate results in inhibi- 
tion of neurite outgrowth; at 21.5 #M, the inhibition is essen- 
tially complete. The ECs0 for the inhibition of neurites in- 
duced by bFGF was 5.67  5:0.07/~M (n  =  5) while that for 
/3NGF was 3.44 5:0.05/xM (n  =  5). Importantly, the con- 
centration of orthovanadate that gave complete inhibition 
(21.5 #M) was not toxic for PC12 cells (Fig.  3, A1-A3); at 
higher concentrations, some cytotoxicity was observed. 
Orthovanadate  also  affected the  neurite  formation pro- 
duced by 8-Br-cAMP. Although analogs of cAMP are not as 
potent in their ability to stimulate differentiation in PC12 
cells as are the neurotrophic growth factors and may employ 
an entirely separate mechanism, the response to 1 mM 8-Br- 
cAMP (Fig. 3 D1) after 2 d of  treatment is quite pronounced. 
As seen in Fig. 3, D2 and D3, orthovanadate also inhibits the 
ability of this cAMP analog to elicit neurites; the magnitude 
of inhibition is comparable to that seen with the growth fac- 
tors (Fig. 2 a,  and 3, B2, B3,  C2 and C3). 
The inhibitory effect of orthovanadate was also observed 
on preformed neurites.  As  shown in  Fig.  4,  treatment of 
PC12  cells for 2  d  with ~3NGF (100 ng/ml),  followed by 
removal of the medium (as well as the ligand) and replace- 
ment with fresh medium containing/3NGF and 0, 4.6, and 
10 t~M orthovanadate results in the loss of  the preformed neu- 
rites (formed after 2  d  exposure of/3NGF) in the samples 
containing the  inhibitor.  Thus,  the processes required to 
maintain neurites are also affected in the same manner by or- 
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Figure  2. Dose-dependent inhibition of orthovanadate on/~NGF or 
bFGF induced neurite outgrowth (a) and neurite regeneration (b). 
(a) PC12 cells were cultured for 2 d in DME containing 1% horse 
serum, #NGF (100 ng/ml) or bFGF (10 ng/ml) in the presence of 
various concentrations of orthovanadate. The % of responsive cells 
in PC12 cells without orthovanadate treatment (control): 68 + 6% 
(n = 5) for BNGF and 80 ± 5 % (n = 5) for bFGE The proportion 
of  responsive cells in the presence of  orthovanadate was normalized 
in each experiment and expressed as percent of the control. --o-, 
NGF; -~-, bFGE (b) PC12 cells were primed with 50 ng/ml/3NGF 
for 7 d and replated. Neurite beating cells were scored 1 d after 
the readdition of  BNGF (100 ng/ml) and addition of  various concen- 
trations of orthovanadate. In the absence of orthovanadate, 82 ± 
4% (n = 4) of the cells was responsive. 77 ±  5% (n =  4) of the 
/3NGF responsive cells were actionomycin D (1 nM) resistant. In 
both panels, values are averages of triplicate determinations from 
four to five separate experiments. Vertical bars represent SEM. 
thovanadate as those necessary to initiate the response. Simi- 
lar results were observed for bFGF (data not shown). 
The inhibitory effect of orthovanadate was also  seen in 
cells that had been primed by earlier exposure to BNGF 
(Figs. 2 b, and 5). As previously documented (Greene and 
Tischler, 1982), when PC12 cells are treated with BNGF for 
1 wk, they respond to new additions of ~NGF and elaborate 
neurites  immediately;  maximal  neurite  generation  is  ob- 
served within 24 h. This effect of BNGF is not blocked by 
actinomycin D  (1 nM) (Fig. 5  C).  However, as with naive 
cells, orthovanadate, at 21.5/~M,  effectively blocks ~NGF 
induction of neurites in these cells indicating that the inhibi- 
tion by orthovanadate does not depend on new protein syn- 
thesis. 
Although orthovanadate is a  good inhibitor of neurotro- 
phic factor induced neurite proliferation in PC12 cells, its 
effects are clearly reversible. As shown in Fig. 6, PC12 cells 
previously treated with either ~NGF or bFGF in the pres- 
ence of orthovanadate (10/zM) can be induced to produce 
neurites by washing (to remove the inhibitor) followed by the 
addition of more growth factor. The treated cells appeared 
as responsive as naive ones. 
Inhibition of  Neurite Proliferation Correlates with the 
Inhibition of  PTPase Activities 
In addition to its PTPase inhibitor activity, orthovanadate 
has been reported to affect other enzymatic activities in vivo. 
Orthovanadate at the concentration used in this study does 
not affect (Na+,K+)-ATPase  activity in A431 cells (Cassel et 
al., 1984), rat myocardial cells (Werdan et al.,  1980), intact 
red blood cells (Canfley, 1978) or adipocytes (Dubyak and 
Kleinzeller, 1980). In addition, in the intact red cell, 50/~M 
vanadate has no effect on the Ca++,Mg++)-ATPase activity 
(Szasz et al.,  1981)  and 0.5  mM  vanadate is  required to 
stimulate Ca  ++ pump (Varecka and Carafoli,  1982). 
To further test the relation of phosphatase inhibitors and 
neurite outgrowth, other substances known to inhibit protein 
tyrosine phosphatases were tested for their effect on neurite 
outgrowth. As with orthovanadate, a good correlation with 
zinc chloride and ammonium molybdate, two other known 
PTPase inhibitors, was observed (Fig. 7). However, they were 
less potent than orthovanadate. This may be due to multiple 
forms of PTPase that have different sensitivities to the vari- 
ous inhibitors (Tonks et al.,  1988). After a 24-h treatment 
with 20 #M orthovanadate, nearly 80%  of/~NGF-induced 
neurite outgrowth and PTPase activity was inhibited. In the 
presence of the highest nontoxic concentration of zinc (250 
~tM) or molybdate (600/~M), only 40 and 50-60 %, respec- 
tively, of ~NGF-induced neurite outgrowth and PTPase ac- 
tivity were inhibited. 
Effects of Orthovanadate on Acetylcholinesterase  and 
Ornithine Decarboxylase Activity 
In addition to morphological changes, 13NGF and bFGF also 
induce cholinergic responsiveness in PC12 cells by regulat- 
ing acetylcholinesterase (ACHE) and cholineacetyltransfer- 
ase activities (Greene and Rein, 1977; Schubert et al., 1977; 
Lucas et al.,  1979,  1980; Rieger et al.,  1980; Greene and 
Rukenstein,  1981). Thus, the induction of AChE activity by 
neurotrophic factors is a biochemical marker for neuronal 
differentiation in PC12 cells. As shown in Fig. 8 a, after ex- 
posure to ~NGF and bFGF for 3 d, the activity of AChE per 
milligram of protein increased by 2.01  5= 0.22 (n  =  5) and 
2.23  +  0.17  (n  =  5)-fold, respectively. When  I0/xM or- 
thovanadate was  coincubated,  the response to /3NGF and 
bFGF was inhibited by 79.88  +  5.69 and 61.80  ±  14.61%, 
respectively, reducing the levels in treated cells to essentially 
those of control values. 
The Journal of Cell Biology, Volume 121,  1993  412 Figure 3.  The inhibition of neurite proliferation induced by/3NGF, bFGE or 8-Br-cAMP by orthovanadate.  Cells were treated  with no 
factor (A/-A3),/3NGF (100 ng/ml) (B1-B3), bFGF (10 ng/ml)(C1-C3),  or 8-Br-cAMP  (1 mM)(D1-D3)  and 0  (.41, B1, C1, D1),  10/~M 
(,42,  B2,  C2, D2), or 21.5/~M (.43, B3,  C3, l)3) orthovanadate.  Other details are given in Materials  and Methods.  Bar,  100/zm. 
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date on PC12 cells pretreated 
with/3NGE  Cells  were  cul- 
tured in the presence of/3NGF 
(100 ng/ml)  for 2  d  and  the 
medium  replaced  with  fresh 
medium containing 0 (B), 4.6 
/~M (C) and 10 #M (D) ortho- 
vanadate with/3NGF (100 rig/ 
ml).  Control  cells  in culture 
for 4  d  with  no  addition  of 
NGF  or  orthovanadate  (A). 
Bar,  100 #m. 
Increase  in  ODC  induced  by  /~NGF,  bFGF,  and  EGF 
represents a short-lived, transcription-dependent response in 
PC12 cells. However, the induction of ODC activity does not 
appear to  be required  for neurite  proliferation by BNGF 
(Feinstein et al.,  1985). Inhibition of either the induction or 
the enzymatic activity of ODC does not alter other responses 
to BNGF (Greene and McGuire, 1978). ODC activity, which 
was greatly increased after a 5-h incubation with BNGF or 
bFGF, was only partially blocked by 10/zM orthovanadate 
pretreatment (Fig.  8 b).  Increasing the orthovanadate con- 
centration to 20/zM did not produce further inhibition (data 
not  shown).  In contrast,  EGF,  which  also  induces  an in- 
crease in ODC,  albeit more modest, was essentially com- 
pletely abolished by the orthovanadate. 
Effect of Orthovanadate on Diacylglycerol Production 
In PC12 cells,/3NGF and bFGF stimulate the hydrolysis of 
Figure  5.  The  inhibition  of 
BNGF-induced neurite prolif- 
eration  by  orthovanadate  in 
PC12 cells  primed by previ- 
ous exposure  to /3NGE Cell 
culture  conditions  were  the 
same as described  in Fig.  2. 
(A) Control cells primed with 
/3NGF (50 ng/ml) for 7 d and 
placed in DME containing 1% 
horse  serum  for  1  d;  (B) 
primed cells (treated as in A, 
after 1 d readdition of BNGF; 
(C)  primed  ceils  (as  in  B) 
with the addition of actinomy- 
cin  D  (1  nM);  (D)  primed 
ceils (as in B) with the addi- 
tion  of  orthovanadate  (21.5 
#M). Bar, 100 #m. 
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Altin and Bradshaw, 1990). A portion of the DG arises from 
phosphoinositide (PI), resulting in the production of inosi- 
tol-l,4,5-trisphosphate,  with the remainder, particularly at 
longer times after growth factor induction, being derived pre- 
dominantly from phosphatidylcholine (Pessin et al.,  1991). 
The formation of  DG from PI occurs by the activation ofphos- 
pholipase C,,  an enzyme known to be phosphorylated on 
tyrosine (Nishibe et al., 1990; Goldschmidt-Clermont et al., 
1991).  To test the effect of orthovanadate on this process, 
PC12 cells were treated with 10/~M inhibitor and DG pro- 
duction in response to a  5-min stimulation by /3NGF and 
bFGF, was measured. Although the level of DG was elevated 
~1.3- to 1.4-fold under these conditions, there was no effect 
by orthovanadate relative to controls (data not shown). Sim- 
ilarly, EGF caused about the same increase and was not af- 
fected by the phosphatase inhibitor either. Thus, the rapid 
onset of phospholipase activation, which is itself a relatively 
transient event (Pessin et al.,  1990), is not affected by pro- 
longing tyrosine phosphorylation. 
Effect of Orthovanadate on the Induction of  Immediate 
Early Response Genes 
Several immediate early response genes, that are character- 
ized by a rapid, transient and cycloheximide-superinducible 
expression, can be induced by EGF, PMA,/3NGF, bFGF, or 
K÷-induced  depolarization  in  PC12  cells  (Herschman, 
1991).  The products of some of these genes, such as TIS 8 
and c-fos, have been identified as nuclear proteins which may 
act as transcriptional activators to mediate growth factor re- 
sponses (Herschman,  1991).  However, the signaling path- 
ways involved in their induction are not fully delineated and 
may involve more than one pathway (Altin et al.,  1991). As 
shown in Fig. 9, basal levels of TIS 8 and c-fos mRNA are 
very low,  as has been previously reported (Kujubu et al., 
Figure 6.  Reversal of the in- 
hibition of neurite outgrowth 
by orthovanadate. Cells were 
cultured for 2 d in DME con- 
taining  1%  horse  serum,  10 
/zM orthovanadate and/3NGF 
(A and B) or bFGF (Cand D). 
In the control group, (A and 
C), cells were washed free of 
orthovanadate and growth fac- 
tors and cultured without fur- 
ther additives for 2 d. In the 
test  group  (B and  D),  cells 
were treated in the same fash- 
ion except that/3NGF (B) and 
bFGF (D)  were  added  after 
washing. Bar, 100/zm. 
1987), and orthovanadate treatment (20 #M for 18 h) did not 
alter these  levels,  pCHOb  mRNA  expression,  which  has 
been shown not to be regulated by growth factors (Altin et 
al.,  1991),  was used to normalize mRNA loading and or- 
thovanadate had no effect on its expression,  as  compared 
with the intensity of ethidium bromide stained 28S and 18S 
ribosomal RNA bands,  suggesting that orthovanadate does 
not act as a nonspecific transcription inhibitor. In contrast 
to the basal condition, the induction of TIS 8, a putative tran- 
scription factor (Herschman,  1991),  by /3NGF,  bFGF,  or 
EGF (after 30 min) was reduced by 62.0 5:7.3 (n =  8) %, 
42.5  5:9.8  (n  =  7)  %,  and 53.6  5:6.9  (n  =  7)  %,  re- 
spectively,  in  cells  pretreated with  20 #M  orthovanadate 
(Fig. 9 a). 
Orthovanadate had an even greater effect on the induction 
ofc-fos, also identified as a transcription factor (Herschman, 
1991) (Fig. 9 b). The response induced by/3NGF was virtu- 
ally eliminated and that by bFGF, nearly so. The amount of 
c-fos induced by EGF was also greatly reduced by orthovana- 
date, although this factor did not induce as much transcript, 
in the absence of orthovanadate, at this time point. Interest- 
ingly, orthovanadate also dramatically affected the transcrip- 
tion induced by the phorbol ester, PMA, of both TIS 8 and 
c-fos. TIS 8 was reduced by 54.2 5:7.2 (n =  7) for the con- 
trois (which was equivalent to that of the growth factors (Fig. 
9 a) and c-fos was completely blocked. However, the induc- 
tion of c-los by PMA, in the absence of orthovanadate was 
much less than that observed for/3NGF and bFGF stimula- 
tion at 30 min, but was similar to that observed for EGE 
These observations suggest that either a part of the PMA in- 
duction mechanism depends on protein tyrosine phosphory- 
lation  or  that  orthovanadate  affects  activities  other  than 
PTPases. 
The time course of TIS 8 response to/3NGF was also ex- 
amined in  cells pretreated with or without orthovanadate 
(Fig.  10).  In the absence of the inhibitor, the maximal re- 
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Figure 7. Effect of orthovanadate, zinc, and molybdate on PTPase 
activities and/~NGF-induced neurite proliferation. PCI2 cells were 
pretreated with or without various concentrations of orthovanadate, 
zinc, or molybdate and in the presence or absence of/3NGF (100 
ng/ml) for 24 h. In the control PC12 cells, 61.9  =t= 3.1% cells bear 
neurites after 100 ng/ml/3NGF stimulation for 24 h. Neurite out- 
growth (open columns) induced by/~NGF in the presence of PTPase 
inhibitors was expressed as percent of control. PTPase activities 
(hatched columns) were measured as described in the section of 
Materials and Methods and the activity in the presence of inhibitor 
was expressed as percent of that in the untreated control. Vertical 
bars represent the SEM.  (n  =  6). 
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Figure 8. The effect of orthovanadate on the stimulation of acetyl- 
cholinesterase (ACHE) (a) and ornithine decarboxylase (ODC) (b) 
by growth factors in PC12 cells. (a) Cells were cultured in DME 
containing 1% horse serum for 3 d in the presence of BNGF (100 
ng/ml) or bFGF (10 ng/ml) and in the presence (hatched) or ab- 
sence (open) of 10 #M orthovanadate. The basal AChE activities 
in the absence of/~NGF or bFGF were: 4.36 +  0.60 nmol/mg pro- 
tein/min (n =  5) in normal PC12 cells and 4.88  Jr 0.70 nmol/mg 
protein/rain (n = 4) in PC12 cells incubated with 10 #M orthovana- 
date. Values are averages of triplicate determinations from four to 
five separate experiments. Vertical bars represent the SEM. (*)p < 
0.05 compared with the control level; (**)p <  0.05 compared with 
the BNGF or bFGF treated group in the absence of orthovanadate. 
(b) Cells were pretreated with 10 t~M orthovanadate for  18 h in 
DME containing 1% horse serum. ODC activities were measured 
after 5 h stimulation with BNGF (100 ng/ml), bFGF (10 ng/ml) or 
EGF (10 ng/ml). The basal ODC activities (expressed as nmol pu- 
trescine formed/rag protein/h) were 0.61  +  0.05 for normal cells 
and 0.73 :t: 0.02 for cells treated with orthovanadate. Vertical bars 
represent standard deviations. 
sponse of TIS 8 transcription to NGF induction was reached 
at 1 h  and the response was essentially zero in 3  h.  In the 
presence of orthovanadate, the diminished TIS 8  response 
followed a similar time course (the loading of the 2- and 3-h 
time points was decreased, as judged by the CHOb marker, 
making it difficult to evaluate whether significant transcripts 
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/~NGF in the presence or absence of  orthovanadate.  PC12 cells were 
grown in complete medium,  pretreated  with or without 20 #M 
orthovanadate  for 18 h and stimulated  with/~NGF (100 ng/ml) for 
the indicated  time.  Other conditions as in Fig. 9. 
independent of PKC-mediated mechanisms.  As also shown 
in Fig.  11, PMA induced down-regulation of PKC has little 
or no effect on EGF induction of TIS 8; the decreased re- 
sponse produced by orthovanadate is  similarly unaffected. 
Figure 9.  Northern blot analyses  of the effect of orthovanadate  on 
the expression of TIS 8 (a), c-fos (b) and SCG 10 (c).  For TIS 8 
and c-fos expression,  PC12 cells were grown in complete medium 
pretreated  with or without 20 #M orthovanadate  for 18 h. Cells 
were stimulated  with BNGF (100 ng/ml), bFGF (10 ng/ml),  PMA 
(50 riM) or EGF (3 ng/ml) for 30 min. Controls (cont) were cells 
without growth factor stimulation.  For SCG 10 expression,  PC12 
cells were cultured in complete medium containing growth factor 
and in the presence or absence of 20 #M orthovanadate  for 24 h. 
Total RNA was extracted  from the cells and fractionated on 0.9% 
(TIS 8 or c-fos) or 1.0% (SCG 10) formaldehyde agarose gels (10 
#g per lane).  The TIS 8 blot (a) was cohybridized with TIS 8 and 
pCHOb probes. The c-fos and SCG 10 blots (b and c) were stripped 
after hybridization with the first probe and rehybridized  with the 
pCHOb probe, resulting  in two different  exposures. 
were still detectable at 120 min). Thus, the decrease in tran- 
scription is not the result of an altered kinetic profile. 
The TIS 8 response to NGF or bFGF stimulation was not 
significantly changed in PC12 cells in which PKC had been 
down regulated (1 #M PMA for 24 h) as previously reported 
(Damon et  al.,  1990;  Sigmund et  al.,  1990;  Altin et  al., 
1991) (Fig.  11). Furthermore, orthovanadate inhibited TIS 8 
induction by/3NGF in PKC-downregulated cells to the same 
extent as in normal PC12 cells,  suggesting that the effect of 
orthovanadate on NGF-induced TIS 8 expression was largely 
Figure 11. Effect of  orthovanadate on the induction ofTIS 8 in PKC- 
down-regulated PC12 cells. PC12 cells were grown in complete me- 
dium (C) and pretreated  with 20 #M orthovanadate  (V), or 1 #M 
PMA (P), or 1 #M PMA and 20 #M orthovanadate  (PV) for 24 h. 
Cells were then stimulated with PMA (50 nM),/~NGF (100 ng/ml), 
or EGF (10 ng/ml) for 30 min under the same conditions as de- 
scribed in Fig.  9. 
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Growth factors also regulate the expression of several sec- 
ondary response genes (also called middle-response genes or 
late-response genes) such as GAP-43 (Federoff et al., 1988), 
transin (Machida et al., 1989,  1991), neurofilament protein 
(Lindenbaum et al., 1988) and SCG 10 (Stein et al., 1988a; 
b). The induction of this class of genes is transcription and 
protein synthesis dependent and their expression follows the 
same time course as the induction of neurite outgrowth. 
Thus, their gene products are considered to be associated 
with the neuronal phenotype. However, as with the immedi- 
ate  early  response  genes,  the  intraceUular  mechanisms 
responsible for their induction are mostly unknown. SCG 10, 
a neural-specific gene that encodes a membrane-bound pro- 
tein, accumulates in the growth cones of developing neurons 
(Stein et al., 1988b) and its induction in PC12 cells is stimu- 
lated by/3NGF, bFGF, EGF, and PMA (Fig. 9 c). (There are 
two transcripts at 1.1 and 2.2 kb detected that are somewhat 
variable in their response;  the smaller one was generally 
stimulated to a lesser degree and was less affected by or- 
thovanadate).  However,  treatment  for  one  day  increased 
SCG 10 mRNA levels in PC12 cells only at low cell density 
(<30% confluency); at higher cell density, the induction of 
SCG 10 by ~NGF or bFGF was inhibited, although the re- 
sponse of neurite outgrowth to these factors (~NGF  and 
bFGF) was not impaired. 
Addition  of orthovanadate  (20  /xM  for  24  h)  did  not 
significantly affect the basal expression of SCG  10 (larger 
transcript). However, orthovanadate at the same concentra- 
tion  did  reduce  the  induction of SCG  10  expression  by 
~NGE EGF or PMA, but not by bFGF (Fig. 9 c). Although 
the induction of SCG 10 may be required for morphological 
differentiation in PC12  cells,  clearly its expression alone 
does not produce the differentiated state. 
Discussion 
The induction of biological responses by many growth fac- 
tors and hormones appears to involve the initial stimulation 
of a receptor tyrosine kinase which leads to its autophos- 
phorylation and to the phosphorylation of a number of pro- 
tein substrates (Cantley et al.,  1991; Friesel et al.,  1989; 
Hempstead et al., 1991; Kaplan et al., 1991a; b; Klein et al., 
1991). These modifications, in turn, activate a number of in- 
tracellular processes,  including an array of additional ki- 
nases, that ultimately lead to modulations in gene expression 
and characterize the phenotypic response to the stimulus. It 
is not entirely clear whether, in any of these cases, signals 
other than those emanating from the receptor kinase are in- 
duced.  In  the  case  of 3NGF,  which  interacts  with  two 
membrane-bound receptors in PC12 cells (as well as other 
responsive cells) (Bothwell, 1991), this is a distinct possibil- 
ity because one of the receptors, designated p75, does not 
contain a tyrosine kinase (Johnson et al.,  1986;  Radeke et 
al., 1987).  However,  it is presently unknown (and still con- 
troversial) what the role of this entity is, if any, in flNGF sig- 
nal transduction. Nonetheless, substantial evidence supports 
the view that receptor-mediated tyrosine phosphorylation is 
the principal initiator of most growth factor actions. It fol- 
lows that compounds known to affect these activities would 
be expected to also affect individual steps in the signalling 
pathway and probably the overall response. 
Sodium  orthovanadate,  which  inhibits  PTPases  and 
thereby the cleavage  of the phosphotyrosine residues pro- 
duced by the activation of the receptor tyrosine kinases, is 
potentially such a compound (Nechay et al., 1986). By anal- 
ogy to  the  phosphodiesterases  that control  the  levels  of 
cAMP  produced  by  adenylate  cyclase-linked  receptors 
(Robison et al., 1971), orthovanadate might be expected to 
affect,  in  a  generally positive manner,  growth  factor re- 
sponses and indeed, orthovanadate stimulates DNA synthe- 
sis in quiescent human fibroblasts (Carpenter, 1981; Smith, 
1983),  old human lymphocytes (Marini et al.,  1987),  sub- 
populations of thymus ceils (Ramanadham and Kern, 1983), 
bone cells (Lau et al., 1988),  and it potentiates the estrogen 
stimulation of proliferation of a mouse leydig cell line (Sato 
et al.,  1987).  Orthovanadate also will replace interleukin-3 
as a growth factor in a mouse cell line (Tojo et al.,  1987). 
In  addition,  it inhibits terminal differentiation of murine 
Friend erythroleukemia cells (English et al.,  1983)  and it 
mimics the effect of aFGF inhibiting some differentiative 
processes in BC3H1 cells. However,  it does not at concen- 
trations of 10 #M for 2 d, induce neurotrophic responses in 
PC12 cells despite the fact that it greatly increases intracellu- 
lar protein tyrosine phosphorylations (Maher,  1989). 
As described in this report, orthovanadate is actually in- 
hibitory of a number of processes induced by three growth 
factors, ~/NGF, bFGF, and EGF, all of which bind to and ac- 
tivate tyrosine kinase containing receptors  in PCI2 cells. 
The growth factor induced expression of several genes rang- 
ing from putative transcriptional regulators (TIS 8 and c-fos) 
to proteins involved in specialized functions (ACHE, ODC 
and SCG  10) were variously affected by the inhibitors. In 
some cases the stimulation was essentially obliterated (c-fos 
and ACHE) while in others it was only partially affected (TIS 
8, SCG 10, and ODC). There was some variation also ob- 
served between factors, e.g., orthovanadate had little effect 
on the bFGF induction of SCG 10, whereas both the flNGF 
and EGF effects were substantially lowered. In contrast, the 
EGF  stimulation of ODC  was  completely blocked while 
those induced by/3NGF and bFGF were only partially in- 
hibited. These differences are not likely to be due to kinetic 
alterations in the response as judged by the induction of TIS 
8 by ~NGF (Fig. 10). These observations underscore previ- 
ous findings (Altin et al., 1991) that the tyrosine phosphory- 
lations arising from individual growth factor receptors must 
be sufficiently unique to account for the variations seen in 
the gene responses. 
It is important to note that the products of these genes are 
not necessarily required for neurite outgrowth. AChE induc- 
tion by/3NGF and bFGF is transcription-dependent (Greene 
and Rukenstein, 1981; Rydel and Greene, 1987) and results 
in a more than twofold increase in the activity with the ap- 
pearance of the 16S form. However, AChE activity is not in- 
duced by EGF or dibutyryl cAMP, even though the latter can 
induce neurite proliferation (see below).  Similarly, ODC 
transcription is rapidly increased by flNGF and bFGF; how- 
ever, increased ODC activity does not appear to be essential 
for neurite proliferation. At the same time, SCG 10, a protein 
associated with neurite proliferation,  is  induced by both 
EGF  and  PMA,  neither  of which  can  induce  neurites. 
Clearly neither the induction of these genes nor the inhibi- 
tion of their expression by orthovanadate is selectively as- 
sociated with the morphological responses (or the inhibition 
thereof). 
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derivative that is considered to function through the activa- 
tion of PKC, were tempered by orthovanadate. The induction 
of SCG 10 was substantially reduced and the two putative 
transcriptional activators, TIS 8 and c-fos,  were even more 
drastically lowered. However, the effect of orthovanadate on 
the induction of TIS 8 expression by/3NGF or EGF in cells 
that had been PKC down-regulated (by previous exposure to 
PMA) was not significantly different than in untreated ceUs 
arguing that the effect of orthovanadate is not directly on 
PKC. It has been reported that in addition to PKC-dependent 
serine/threonine-phosphorylation, PMA stimulates protein 
tyrosine phosphorylation of a 42-kD protein in chicken em- 
bryo fibroblasts (Vila and Weber,  1988)  and in Swiss 3T3 
cells (Kazlauskas and Cooper, 1988). More recently, a MAP 
kinase was identified in PC12 cells. The MAP kinase kinases 
are activated by NGF and are dependent on serine/threonine 
phosphorylation for activity. They can promote phosphory- 
lation of serine/threonine and tyrosine residues on MAP ki- 
nases (Gomez and Cohen,  1991). In addition, membrane 
PTPase activity may be regulated by PKC (Brautigan and 
Pinalult, 1991). These observations are consistent with the 
view that PMA effects  are,  at least in part,  also induced 
through tyrosine phosphorylations probably involving solu- 
ble kinases as opposed to membrane-bound enzymes. These 
findings also support previous reports (Damon et al., 1990; 
Sigmund et al.,  1990;  Altin et al.,  1991) that induction of 
immediate early response genes by/~NGF and bFGF re- 
quires a signal transduction pathway other than PKC. This 
alternative pathway also is likely to involve tyrosine kinases 
and therefore may be susceptible to orthovanadate effects. 
The effect of orthovanadate on the inhibition of neurite 
proliferation was reversible and independent of the state of 
differentiation, i.e., inhibited cells would produce neurites 
when orthovanadate was removed (and the cells stimulated 
by the appropriate growth factor) and preformed neurites 
were retracted when orthovanadate was added even in the 
presence of growth factors. Orthovanadate also inhibited the 
production of neurites from primed cells  (previously ex- 
posed to/3NGF), a transcriptional-independent event. These 
findings clearly support the conclusion that orthovanadate 
interferes with the signal transduction cascade as its effect is 
equivalent to  removing the growth factor itself.  It is,  of 
course,  well established that the differentiative actions of 
BNGF and bFGF on PC12 cells are entirely reversible and 
that the maintenance of neurites requires the continued pres- 
ence of the factors (Greene and Tischler, 1982).  However, 
it should be noted that the results presented here do not 
definitively establish  that  the  effect of orthovanadate on 
differentiation is via the inhibition of protein tyrosine phos- 
phatases although the parallel effects of zinc and molybdate 
and the excellent correlation between inhibitions of neurite 
proliferation and phosphatase activity support this view. 
If the effects of orthovanadate on differentiation arise from 
phosphatase inhibition, it is possible that multiple enzymes 
are involved. However,  several of the observations suggest 
that the effect is more likely related to the action of down- 
stream kinases (nonreceptor tyrosine kinases) than those as- 
sociated with the receptors themselves. In general, ligand- 
induced tyrosine phosphorylation is transient and is rapidly 
superseded by serine/threonine pbosphorylations in PC12 
cells (H.  Hondermarck, S.  Rattioni, Y.  Y. Wu and R.  A. 
Bradshaw, unpublished observations). The lack of effect of 
orthovanadate on DG production suggests that it does not re- 
sult in the significant inhibition of phospholipase C~ that in- 
itiates the cleavage phosphoinositide. This enzyme is known 
to be phosphorylated by the/~NGF receptor in PC12 cells, an 
event that presumably leads to its activation (Goldschmidt- 
Clermont et al., 1991; Kim et al., 1991; Vetter et al., 1991; 
Rhee, 1991; Obermeier et al., 1993). However, most DG in- 
duced by/~NGF and bFGF in PC12  cells arises from the 
cleavage of phosphatidylcholine (Pessin et al., 1991) and the 
pathway and locations are not yet defined. It may arise from 
the stimulation of PKC by the DG formed from PI or it may 
involve enzymes directly stimulated by the receptor kinase 
(as with phospholipase CO. Thus, the dependence on tyro- 
sine phosphorylation may be direct or indirect;  in either 
case, it is not apparently affected by orthovanadate support- 
ing the conclusion that the inhibitions observed are not due 
to the perpetration of receptor-mediated phosphorylations. 
Further support for this view is provided by the observa- 
tions that the neurite induction by 8-Br-cAMP is inhibited by 
orthovanadate and the production of DG is not. The induc- 
tion of neurite outgrowth by/~NGF or bFGF is not mediated 
by a cAMP-dependent pathway (Frazier et al., 1973; Chijiwa 
et al.,  1990;  Damon et al.,  1990;  Glowacka and Wagner, 
1990; Ginty et al., 1991) nor is there any direct connection 
of cAMP  with  any  tyrosine kinase  containing  receptor. 
Rather cAMP (or appropriate analogs) stimulates intracellu- 
lar kinases that likely in turn induce one or more tyrosine 
kinases  (probably  in  part  overlapping  those  induced  by 
/~NGF and bFGF) that leads to the observed, albeit modest, 
neurite proliferation. Of course, it is also possible that the 
effect of the orthovanadate on the cAMP response is entirely 
unrelated to phosphatase inhibition. Because cAMP (and its 
analogs) do not induce as robust a response as/3NGF and 
bFGF, the kinase activations are probably not entirely over- 
lapping. However, they may involve the same orthovanadate 
sensitive step(s). 
The conclusion that orthovanadate may regulate the tyro- 
sine phosphorylation of proteins  stimulated by /3NGF  or 
bFGF, downstream from their receptors, is also consistent 
with both our phosphotyrosine immunoblot data and other 
observations.  It has been reported that exposure of PC12 
cells to/3NGF or bFGF rapidly stimulated threonine and 
tyrosine phosphorylation of MAP kinases followed by an in- 
crease in their activities (Anderson et al., 1990; Tsao et al., 
1990; Boulton et al., 1991; Miyasaka et al., 1991; Schanen- 
King et al., 1991; Seger et al., 1991; Tsao and Greene, 1991). 
The MAP kinase activities can be completely inactivated by 
treatment with either phosphatase 2A, a protein phosphatase 
specific for phosphoserine and phosphothreonine, or CD45, 
a PTPase, and the inactivation is preventable by okadaic acid 
or orthovanadate, respectively (Anderson et al., 1990;  Go- 
mez and Cohen, 1991). Moreover, it was reported by Tsao 
and Greene (1991) that orthovanadate treatment (0.5 to 1.0 
mM) resulted in the activation MAP kinase activity in vivo. 
NGF down-regulated MAP kinase activity can be restimu- 
lated by orthovanadate and okadaic acid. Tyrosine and threo- 
nine phosphorylation of MAP kinase have been implicated 
in the regulation of cell growth and differentiation in PC12 
cells (Boulton et al.,  1991). In addition, pp60  're has also 
been implicated in the regulation of cell differentiation in 
PC12  cells  (Alema,  1985;  Rausch et al.,  1989;  Kremer 
et al.,  1991) and v-src  constructs will rescue NGF  non- 
responsive PC12 cell mutants (Eveleth et al.,  1989).  It has 
Wu and Bradshaw  Effect of Orthovanadate on PC12 Cells  419 been suggested in a recent report by Zheng et al. (1992) that 
overexpression of a protein tyrosine phosphatase activates 
pp60  '~ and leads to transformation of rat embryo fibroblast. 
In PC12 cells, it is possible that orthovanadate treatment in- 
creases the phosphorylation of the carboxy-terminal negative 
regulatory  (Tyr-527)  site  of  pp60  "~  and  decreases  the 
pp60  "c activities (Cooper et al.,  1986; Kmiecik and Shallo- 
way  1987;  Piwnica-Worms et al.,  1987;  Cartwright et al., 
1987), which is required for the actions of BNGF and bFGF 
(Kremer  et al.,  1991).  Finally,  regulation of the cell cycle 
specific proteins and kinases by growth factors may be partly 
responsible for the stimulation of cell growth and differen- 
tiation (Matsushime et al.,  1991).  Orthovanadate treatment 
might have affected the activity of a specific tyrosine phos- 
phatase,  such as CDC25,  which directly  activates p34  c°c2 
(Strausfeld et al., 1991; Dunphy and Kumagai, 1991; Gautier 
et al.,  1991). 
Although our observations do not specifically identify the 
step(s) that is sensitive to PTPase inhibition,  they strongly 
support  the  view  that  they  affect  the  substrates  of  non- 
receptor  kinases  and that these  enzymes  are  essential  in 
growth factor induced responses.  They further suggest that 
agents such as PMA and 8-Br-cAMP may also be able to ac- 
tivate these entities,  at least to some extent,  and that these 
stimulations are essential for their various responses as well. 
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